Wang, Zhi

Ginsenoside Rb1 preconditioning protects against myocardial infarction after regional ischemia and reperfusion by activation of phosphatidylinositol-3-kinase signal transduction. [electronic resource] - Cardiovascular drugs and therapy Dec 2008 - 443-52 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1573-7241

10.1007/s10557-008-6129-4 doi


Androstadienes--pharmacology
Animals
Blood Pressure--drug effects
Blotting, Western--methods
Creatine Kinase--antagonists & inhibitors
Creatine Kinase, MB Form--antagonists & inhibitors
Dimethyl Sulfoxide--administration & dosage
Drug Administration Schedule
Drug Therapy, Combination
Ginsenosides--antagonists & inhibitors
Heart Rate--drug effects
Injections, Intravenous
Ischemic Preconditioning, Myocardial--methods
L-Lactate Dehydrogenase--antagonists & inhibitors
Male
Molecular Structure
Myocardial Infarction--complications
Myocardial Reperfusion Injury--complications
Panax--chemistry
Pharmaceutical Vehicles--chemistry
Phosphatidylinositol 3-Kinases--metabolism
Phosphorylation--drug effects
Placebos--administration & dosage
Rats
Rats, Sprague-Dawley
Signal Transduction--drug effects
Tetrazolium Salts
Troponin T--antagonists & inhibitors
Wortmannin